Európska únia - estónčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - rivaroksabaan - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - antitrombootilised ained - täiskasvanud patsientidel, kellele tehti plaaniline puusa- või põlveliigese asendamise operatsiooni venoosse trombemboolia (vte) ennetamine. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 haemodynamically ebastabiilne pe patsientidel). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 ja 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Estónsko - estónčina - Ravimiamet

zentiva k.s. - klopidogreel - õhukese polümeerikattega tablett - 75mg 14tk; 75mg 90tk; 75mg 30tk

Európska únia - estónčina - EMA (European Medicines Agency)

merck sharp dohme limited - vorapaksaarsulfaat - müokardi infarkt - antitrombootilised ained - zontivityis märgitud vähendamise atherothrombotic sündmuste täiskasvanud patsientidel, kellel on - on esinenud müokardiinfarkt (mi)co-manustada atsetüülsalitsüülhape (asa) ja vajaduse korral clopidogrel; või - sümptomaatiline perifeersete arterite haigus(pad), co-manustada atsetüülsalitsüülhape (asa) või vajaduse korral clopidogrel.

Estónsko - estónčina - Ravimiamet

ratiopharm gmbh - omeprasool - gastroresistentne kõvakapsel - 20mg 15tk; 20mg 100tk; 20mg 30tk; 20mg 60tk

Estónsko - estónčina - Ravimiamet

sandoz pharmaceuticals d.d. - omeprasool - gastroresistentne kõvakapsel - 10mg 28tk; 10mg 15tk; 10mg 7tk; 10mg 20tk

Estónsko - estónčina - Ravimiamet

jsc olainfarm - omeprasool - gastroresistentne kõvakapsel - 10mg 140tk; 10mg 60tk; 10mg 15tk; 10mg 500tk; 10mg 56tk; 10mg 50tk; 10mg 100tk; 10mg 28tk

Estónsko - estónčina - Ravimiamet

stada arzneimittel ag - omeprasool - gastroresistentne kõvakapsel - 20mg 50tk; 20mg 90tk; 20mg 250tk; 20mg 5tk; 20mg 30tk; 20mg 280tk; 20mg 100tk; 20mg 105tk; 20mg 500tk

Estónsko - estónčina - Ravimiamet

stada arzneimittel ag - omeprasool - gastroresistentne kõvakapsel - 10mg 56tk; 10mg 90tk; 10mg 280tk; 10mg 60tk; 10mg 28tk; 10mg 30tk; 10mg 14tk; 10mg 98tk; 10mg 500tk; 10mg 5tk; 10mg 15tk; 10mg 100tk

Estónsko - estónčina - Ravimiamet

pro.med.cs praha a.s. - omeprasool - gastroresistentne kõvakapsel - 10mg 14tk

Estónsko - estónčina - Ravimiamet

jsc olainfarm - omeprasool - gastroresistentne kõvakapsel - 20mg 60tk; 20mg 7tk; 20mg 140tk; 20mg 56tk; 20mg 100tk; 20mg 14tk; 20mg 50tk; 20mg 280tk